Adzynma TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: recombinant adamts13
Brand name
(ARTG)
: ADZYNMA apadamtase alfa/cinaxadamtase alfa 1500 IU powder and solvent for injection vialsWhat this medicine is used for
(ARTG)
ADZYNMA is a recombinant ADAMTS13 (rADAMTS13) enzyme replacement therapy (ERT) indicated for the treatment of ADAMTS13 deficiency in patients with congenital thrombotic thrombocytopenic purpura (cTTP).,ADZYNMA can be used for all age groups.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- White lyophilised powder
Component :
- Injection, solvent for
- Intravenous
- Clear and colourless solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 powder vial + 1 solvent vial + reconstitution and administration devices pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
